QA Wolf
QA Wolf helps engineering teams achieve 80% automated test coverage end-to-end in just four months.
Here's an overview of what you get in the box, whether it's 100 or 100,000 tests.
• Automated end-to-end testing for 80% of the user flows in 4 months. The tests are written in Playwright, an open-source tool (no vendor lock-in; you own the code).
• Test matrix and outline in the AAA framework.
• Unlimited parallel testing on any environment of your choice.
• We host and maintain 100% parallel-run infrastructure.
• Maintenance of flaky and broken test for 24 hours.
• Guaranteed 100% reliable results -- zero flakes.
• Human-verified bugs sent via your messaging app as a bug report.
• CI/CD Integration with your deployment pipelines and issue trackers.
• Access to full-time QA Engineers at QA Wolf 24 hours a day.
Learn more
Stack AI
AI agents that interact and answer questions with users and complete tasks using your data and APIs. AI that can answer questions, summarize and extract insights from any long document. Transfer styles and formats, as well as tags and summaries between documents and data sources. Stack AI is used by developer teams to automate customer service, process documents, qualify leads, and search libraries of data. With a single button, you can try multiple LLM architectures and prompts. Collect data, run fine-tuning tasks and build the optimal LLM to fit your product. We host your workflows in APIs, so that your users have access to AI instantly. Compare the fine-tuning services of different LLM providers.
Learn more
Tempus
Tempus AI, a prominent health technology firm based in Chicago, Illinois, is dedicated to transforming patient care through advanced artificial intelligence and precision medicine. By utilizing data and AI, the company strives to create personalized treatment plans across a range of medical specialties, such as oncology, cardiology, radiology, and mental health. Their all-encompassing platform combines genomic sequencing, clinical data, and AI-powered analytics, equipping healthcare providers and researchers with actionable insights. Tempus offers a holistic understanding of patients via various testing methods, including tissue and liquid biopsies, DNA and RNA sequencing, somatic and germline tests, as well as tumor-normal matched profiling and minimal residual disease monitoring options. Additionally, they provide a swift and dependable platform for ordering tests, gaining patient insights, and seamlessly integrating AI-driven technologies into practice. Furthermore, Tempus features an innovative generative AI-enabled clinical assistant that places patient insights readily at your fingertips, enhancing the overall efficiency of healthcare delivery. This commitment to leveraging cutting-edge technology exemplifies Tempus AI's mission to improve health outcomes and advance medical research.
Learn more
Atomwise
Our innovative AI engine is revolutionizing the drug discovery process, enabling the creation of superior medications at an accelerated pace. The breakthroughs we achieve contribute to the development of medicines more efficiently and effectively. Our portfolio of AI-driven discoveries encompasses entirely owned and collaboratively developed pipeline assets, supported by leading investors in the industry. Atomwise has engineered a cutting-edge machine-learning discovery platform that merges the capabilities of convolutional neural networks with extensive chemical libraries to identify new small-molecule treatments. The key to transforming drug discovery through AI lies in our talented team. We are committed to enhancing our AI platform and leveraging it to revolutionize the discovery of small molecule drugs. It is essential that we confront the most daunting and seemingly insurmountable targets, streamlining the entire drug discovery process to provide developers with increased opportunities for success. Enhanced computational efficiency allows us to screen trillions of compounds virtually, significantly boosting the chances of finding viable solutions. Our impressive model accuracy has successfully addressed the persistent issue of false positives, underscoring the reliability of our approach. Ultimately, our dedication to innovation and excellence sets us apart in the quest for breakthrough therapies.
Learn more
